Knowstox

Fundamentals snapshot

Cabot Corporation

CBT · NYQ · Basic Materials · Specialty Chemicals

Current price

$79.63

52-week range

$58.33 - $94.53

Market cap

$4.11B

One-glance verdict

Undervalued

$156.45 our estimate vs market $79.63

Wall Street consensus: $91.33 (-41.6% lower than our fair-value estimate)

Balance sheet

Watch

8.17x Adequate

Net debt $1.04B. Interest coverage shows how many times profit covers the interest bill.

What this company does

Cabot Corporation

Cabot Corporation is an ingredients company that creates specialty chemicals used by other manufacturers to make their products better. A large part of its business comes from making "carbon black," a crucial material that strengthens car tires, but it also sells additives that improve everything from electric vehicle batteries to printer ink. Because its products are essential components, Cabot's success is often tied to the health of major industries like automotive and electronics, which buy these ingredients to build their final goods.

Price history

How the share price has moved

Loading price history…

Earnings history

Last 8 quarters — what happened

Click any quarter to read the call summary and what the numbers say.

Free cash flow by quarter (oldest to newest)
FY2024 Q4 $112.00M FY2025 Q1 $47.00M FY2025 Q2 $1.00M FY2025 Q3 $188.00M FY2025 Q4 $155.00M FY2026 Q1 $57.00M FY2026 Q2 $32.00M FY2026 Q3 $37.00M
Revenue $982.00M
Net income $6.00M
Diluted EPS 0.12
Operating cash flow $75.00M
Free cash flow $37.00M
Revenue $904.00M
Net income $68.00M
Diluted EPS 1.27
Operating cash flow $77.00M
Free cash flow $32.00M
Revenue $849.00M
Net income $73.00M
Diluted EPS 1.37
Operating cash flow $126.00M
Free cash flow $57.00M
Revenue $899.00M
Net income $43.00M
Diluted EPS 0.80
Operating cash flow $219.00M
Free cash flow $155.00M
Revenue $923.00M
Net income $101.00M
Diluted EPS 1.86
Operating cash flow $249.00M
Free cash flow $188.00M
Revenue $936.00M
Net income $94.00M
Diluted EPS 1.69
Operating cash flow $73.00M
Free cash flow $1.00M
Revenue $955.00M
Net income $93.00M
Diluted EPS 1.67
Operating cash flow $124.00M
Free cash flow $47.00M
Revenue $1.00B
Net income $137.00M
Diluted EPS 2.41
Operating cash flow $204.00M
Free cash flow $112.00M

Is it cheap or expensive?

Fair value $156.45 vs current price $79.63

Wall Street consensus is the average analyst price target: $91.33 (-41.6% lower than our fair-value estimate).

Our most-likely fair value is $156.45 a share — about 96.5% above today's price of $79.63, so the stock currently looks cheap (undervalued).

undervalued

We estimate the cash this business should generate over the next 10 years and beyond, then convert it to today's money for a fair value per share, in its trading currency. Cautious, middle and optimistic growth cases give a range. Not for banks/insurers.

Base

Growth 4.0% · Discount 7.3% · Terminal 2.5%

$156.45

Bear

Growth 2.5% · Discount 7.3% · Terminal 2.5%

$141.43

Bull

Growth 9.0% · Discount 7.3% · Terminal 2.5%

$216.42

Is it drowning in debt?

Watch

Net debt $1.0B. Interest coverage 8.2x.

Net debt $1.04B
Interest coverage 8.17x

Cabot Corporation's profit covers its interest bill about 8.2 times over. which is stronger than every peer shown here and 1 peers sit below 1x, which is the danger zone where profit does not fully cover the interest bill.

Watch
Worse cushion Baseline Better cushion
CBT BASELINE Cabot Corporation

Total debt $1.29B Interest coverage 8.17x This is the baseline the peer rows are being compared against.

Total debt $1.15B Interest coverage 1.63x -80% vs CBT Carries about 5.0x less debt cushion than CBT.

Total debt $1.48B Interest coverage 1.44x -82% vs CBT Carries about 5.7x less debt cushion than CBT.

Total debt $12.40B Interest coverage 1.09x -87% vs CBT Carries about 7.5x less debt cushion than CBT.

Total debt $2.50B Interest coverage -0.27x -100% vs CBT This peer has almost no interest-payment cushion compared with CBT.

Total debt $1.24B Interest coverage 3.40x -58% vs CBT Carries about 2.4x less debt cushion than CBT.

What you should know

The case for and against CBT

3 Rewards 1 Risk

Rewards

  • Returns 13.3% on equity, ahead of 66% of its peers.
  • Free cash flow was positive in 9/10 years.
  • Trades at 22.3x P/E vs peer median 71.9x (69.0% cheaper).

Risks

  • Stock trades 59.7% above its 5-year average P/E.

The numbers

All the key metrics, grouped by purpose

Tap any ? icon to learn what it means.

Valuation

How expensive the stock looks

P/E (TTM)
22.31x
Forward P/E
11.40x
P/B
2.56x
P/S
1.13x
EV/EBITDA
7.12x
PEG ratio
1.00x

Profitability

How much profit each dollar creates

Gross margin
24.2%
Operating margin
14.3%
Net margin
5.2%
ROE
13.3%
ROA
8.9%

Health

Liquidity and balance-sheet strength

Debt / equity
0.74x
Current ratio
1.47x
Quick ratio
0.86x
Total debt
$1.29B
Total cash
$250.00M

Growth

How the business has been compounding

Revenue TTM
$3.63B
Revenue 5Y CAGR
2.2%
EPS TTM
3.57
EPS 5Y CAGR
18.5%

Cash flow

How much cash the business throws off

Operating CF TTM
$497.00M
Free CF TTM
$391.00M
FCF margin
10.8%

Dividend

Shareholder payout

Yield
2.3%
Payout ratio
51.0%
Last ex-div date
2026-08-28